Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Greenberg

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous DoseScott A Halperin, Catherine Donovan, Gary S Marshall, et al.
Expert Review of Vaccines|May 2, 2018
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysisJason K H Lee, Gary K L Lam, Thomas Shin, et al.
Vaccine|October 15, 2013
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trialPeter Tsang, Geoffrey J Gorse, Cynthia B Strout, et al.
Vaccine|May 15, 2003
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infantsSylvia H Yeh, Kenneth M Zangwill, Hang Lee, et al.
The Pediatric Infectious Disease Journal|August 22, 2021
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis VaccinationJohn Hansen, Michael D Decker, Edwin Lewis, et al.
Journal of Clinical Microbiology|February 5, 2002
Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adultsRobert M Wadowsky, Elias A Castilla, Stella Laus, et al.
Vaccine|April 23, 2003
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infantsKenneth M Zangwill, David P Greenberg, Chung-Yin Chiu, et al.
American Journal of Preventive Medicine|September 20, 2005
Parental perspectives on influenza immunization of children aged 6 to 23 monthsMary Patricia Nowalk, Richard K Zimmerman, Chyongchiou J Lin, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2017
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017Mark D Gershman, Kristina M Angelo, Julian Ritchey, et al.
American Journal of Preventive Medicine|November 24, 2004
Feasibility of influenza immunization for inner-city children aged 6 to 23 monthsRichard K Zimmerman, Alejandro Hoberman, Mary Patricia Nowalk, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of the Pediatric Infectious Diseases Society|February 14, 2018
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous DoseScott A Halperin, Catherine Donovan, Gary S Marshall, et al.
Expert Review of Vaccines|May 2, 2018
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysisJason K H Lee, Gary K L Lam, Thomas Shin, et al.
Vaccine|October 15, 2013
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trialPeter Tsang, Geoffrey J Gorse, Cynthia B Strout, et al.
Vaccine|May 15, 2003
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infantsSylvia H Yeh, Kenneth M Zangwill, Hang Lee, et al.
The Pediatric Infectious Disease Journal|August 22, 2021
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis VaccinationJohn Hansen, Michael D Decker, Edwin Lewis, et al.
Journal of Clinical Microbiology|February 5, 2002
Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adultsRobert M Wadowsky, Elias A Castilla, Stella Laus, et al.
Vaccine|April 23, 2003
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infantsKenneth M Zangwill, David P Greenberg, Chung-Yin Chiu, et al.
American Journal of Preventive Medicine|September 20, 2005
Parental perspectives on influenza immunization of children aged 6 to 23 monthsMary Patricia Nowalk, Richard K Zimmerman, Chyongchiou J Lin, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2017
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017Mark D Gershman, Kristina M Angelo, Julian Ritchey, et al.
American Journal of Preventive Medicine|November 24, 2004
Feasibility of influenza immunization for inner-city children aged 6 to 23 monthsRichard K Zimmerman, Alejandro Hoberman, Mary Patricia Nowalk, et al.
Pageof 7